2014 - Fellow of the Royal Society, United Kingdom
Member of the Association of American Physicians
Fellow of The Academy of Medical Sciences, United Kingdom
His Internal medicine study frequently draws connections to adjacent fields such as Disease. In his papers, he integrates diverse fields, such as Calcium and Calcium signaling. He undertakes multidisciplinary studies into Calcium signaling and Calcium in his work. In his works, Rajesh V. Thakker undertakes multidisciplinary study on Receptor and G protein. By researching both G protein and Receptor, Rajesh V. Thakker produces research that crosses academic boundaries. While working on this project, he studies both Gene and HEK 293 cells. In most of his HEK 293 cells studies, his work intersects topics such as Genetics. Rajesh V. Thakker frequently studies issues relating to Extracellular and Genetics. His work blends Extracellular and Gene studies together.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Maria Luisa Brandi;Robert F. Gagel;Alberto Angeli;John P. Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2001)
Gastroenteropancreatic neuroendocrine tumours.
Irvin M Modlin;Kjell Oberg;Daniel C Chung;Robert T Jensen.
Lancet Oncology (2008)
Primer on the metabolic bone diseases and disorders of mineral metabolism
John P. Bilezikian;Roger Bouillon;Thomas Clemens;Juliet Compston.
Papagerakis, P; Mitsiadis, T A (2008). Primer on the metabolic bone diseases and disorders of mineral metabolism. In: Rosen, Clifford J; Compston, Juliet E; Lian, Jane B. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Washington, DC: John Wiley & Sons, 491-496. (2013)
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)
Rajesh V. Thakker;Paul J. Newey;Gerard V. Walls;John Bilezikian.
The Journal of Clinical Endocrinology and Metabolism (2012)
Guidelines for the management of thyroid cancer
Petros Perros;Kristien Boelaert;Steve Colley;Carol Evans.
Clinical Endocrinology (2014)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
John K Ramage;A Ahmed;J Ardill;N Bax.
Gut (2005)
Identification of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene. The European Consortium on MEN1
Irma Lemmens;Wim J. M. Van de Ven;Koen Kas;Chang X. Zhang.
Human Molecular Genetics (1997)
A common molecular basis for three inherited kidney stone diseases
Sarah E. Lloyd;Simon H. S. Pearce;Simon E. Fisher;Klaus Steinmeyer.
Nature (1996)
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome
J.D. Carpten;C.M. Robbins;A. Villablanca;L. Forsberg.
Nature Genetics (2002)
Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene
Manuel C. Lemos;Rajesh V. Thakker.
Human Mutation (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Washington University in St. Louis
Medical Research Council
University of Melbourne
Guy's and St Thomas' NHS Foundation Trust
University of Oxford
University of Zurich
University of Oxford
Medical Research Council
National University of Singapore
National Institutes of Health
Toyota Technological Institute at Chicago
Microsoft (United States)
Technical University of Berlin
Stanford University
Queensland University of Technology
Institut de Chimie des Substances Naturelles
University of Vermont
University College London
ETH Zurich
University of Wollongong
Iowa State University
Innsbruck Medical University
Jewish General Hospital
University of Nevada, Reno
University of Siena
Boston University